Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: An immunohistochemical and fluorescent in situ hybridization study

Modern Pathology

Volumn 17, Issue 8, 2004, Pages 895-904

  Ooi, Akishi ^a   Takehana, Takuo ^a   Li, Xiaoling ^a   Suzuki, Shioto ^a   Kunitomo, Kazuyoshi ^a   Iino, Hiroshi ^a   Fujii, Hideki ^a   Takeda, Yasuhisa ^a   Dobashi, Yoh ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Colorectal cancer; EGFR; FISH; Gene amplification; HER 2; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; AMPLICON; ARTICLE; CANCER CELL; CENTROMERE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA HYBRIDIZATION; DOUBLE MINUTE CHROMOSOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 3343024502     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800137     Document Type: Article

References (40)

1. Yamamoto T, Ikawa S, Akiyama T, et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 1986;319:230-234.
2. Treish I, Schwartz R, Lindley C. Pharmacology and therapeutic use of trastuzumab in breast cancer. Am J Health Syst Pharm 2000;57:2063-2076.
3. Cohen MH, Williams GA, Sridhara R, et al. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 2003;8:303-306.
4. Takehana T, Kunitomo K, Kono K, et al. Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer 2002;98:833-837.
5. Ooi A, Kobayashi M, Mai M, et al. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. Lab Invest 1998;78:345-351.
6. Ishikawa T, Kobayashi M, Mai M, et al. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. Am J Pathol 1997;151:761-768.
7. Hirashima N, Takahashi W, Yoshii S, et al. Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 2001;14:556-562.
8. Takehana T, Kunitomo K, Suzuki S, et al. Overexpression of epidermal growth factor receptor in gastric carcinomas is rare but occurs predominantly by gene amplification. Clin Gastroenterol Hepatol 2003;1:438-445.
9. Flemming ID, Cooper JS, Earl Henson D, et al. (eds). Colon and rectum, In: AJCC Cancer Staging Manual, 5th edn. Lippincott Williams and Wilkins: Philadelphia, PA, 1977, pp 83-88.
10. Hamilton SR, Vogelstein B, Sobin LH, et al. Carcinomas of the colon and rectum, In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours. IARC Press: Lyon, France, 2000, pp 105-119.
11. Kobayashi M, Ooi A, Oda Y, et al. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues. Hum Pathol 2002;33:21-28.
12. Kunitomo K, Takehana T, Inoue S, et al. Detection of c-erbB-2 (HER-2/neu) amplification in breast carcinoma by fluorescence in situ hybridization on tissue sections and imprinted cells. Pathol Int 2002;52:451-457.
13. Kitayama Y, Igarashi H, Sugimura H. Initial intermittent microwave irradiation for fluorescence in situ hybridization analysis in paraffin-embedded tissue sections of gastrointestinal neoplasia. Lab Invest 2000;80:779-781.
14. Thomson TA, Hayes MM, Spinelli JJ, et al. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol 2001;14:1079-1086.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
16. Nathanson DR, Culliford ATT, Shia J, et al. HER 2/neu expression and gene amplification in colon cancer. Int J Cancer 2003;105:796-802.
17. Arnaout AH, Dawson PM, Soomro S, et al. HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. J Clin Pathol 1992;45:726-727.
18. Kay EW, Mulcahy H, Walsh CB, et al. Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma. Histopathology 1994;25:455-461.
19. Caruso ML, Valentini AM. Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer. Anticancer Res 1996;16:3813-3818.
20. D'Emilia J, Bulovas K, D'Ercole K, et al. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 1989;4:1233-1239.
21. Nakae S, Shimada E, Urakawa T. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma. J Surg Oncol 1993;54:246-251.
22. Osako T, Miyahara M, Uchino S, et al. Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival. Oncology 1998;55:548-555.
23. McKay JA, Loane JF, Ross VG, et al. c-erbB-2 is not a major factor in the development of colorectal cancer. Br J Cancer 2002;86:568-573.
24. Kapitanovic S, Radosevic S, Kapitanovic M, et al. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 1997;112:1103-1113.
25. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712.
26. Lemoine NR, Jain S, Silvestre F, et al. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer 1991;64:79-83.
27. Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-2460.
28. Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 2001;92:1331-1346.
29. Nishikawa R, Ji XD, Harmon RC, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994;91:7727-7731.
30. Radinsky R, Risin S, Fan D, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19-31.
31. Layfield LJ, Bernard PS, Goldstein NS. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma. J Surg Oncol 2003;83:227-231.
32. Fried M, Feo S, Heard E. The role of inverted duplication in the generation of gene amplification in mammalian cells. Biochim Biophys Acta 1991;1090:143-155.
33. Dolf G, Meyn RE, Curley D, et al. Extrachromosomal amplification of the epidermal growth factor receptor gene in a human colon carcinoma cell line. Genes Chromosomes Cancer 1991;3:48-54.
34. Ruiz JC, Wahl GM. Chromosomal destabilization during gene amplification. Mol Cell Biol 1990;10:3056-3066.
35. Isola J, Chu L, DeVries S, et al. Genetic alterations in ERBB2-amplified breast carcinomas. Clin Cancer Res 1999;5:4140-4145.
36. Barlund M, Tirkkonen M, Forozan F, et al. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 1997;20:372-376.
37. Bergstein I. Molecular alterations in breast cancer, In: Bowcock AM (ed). Breast Cancer. Humana Press: Totowa, NJ, 1999, pp 143-170.
38. Grandis JR, Tweardy DJ, Melhem MF. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res 1998;4:13-20.
39. Hirsch FR, Varella-Garcia M, Bunn Jr PA, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003;21:3798-3807.
40. Baselga J. New therapeutic agents targeting the epidermal growth factor receptor. J Clin Oncol 2000;18:54S-59S.